Article

Best First Line Tyrosine Kinase Inhibitor for Chronic Phase Chronic Myeloid Leukemia in Adults: A Network Meta-Analysis

2020-11-05

Abstract excerpt

<h4>Background: </h4> For many years chronic myeloid leukemia (CML) remained a leukemic subtype in which little improvement was gained with regard to overall survival (OS). Imatinib, the first tyrosine kinase inhibitor (TKI), completely changed patients’ life expectancy. Although many studies have compared the use of imatinib and more recent TKIs in patients with newly diagnosed chronic phase (CP) CML, they have n...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 50037cb8-7349-56f6-aeef-f72372cdac28
DOI: 10.21203/rs.3.rs-102006/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Best First Line Tyrosine Kinase Inhibitor for Chronic Phase Chronic Myeloid Leukemia in Adults: A Network Meta-AnalysisDOI 10.21203/rs.3.rs-102006/v1Read

Comparative Effectiveness of Newer Tyrosine Kinase Inhibitors Versus Imatinib in the First-Line Treatment of Chronic-Phase Chronic Myeloid Leukemia Across Risk Groups: A Systematic Review and Meta-Analysis of Eight Randomized Trials.Semantic proximity Read

Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in OncologySemantic proximity Read

A review of the European LeukemiaNet recommendations for the management of CML.Semantic proximity Read

Update on the use of hydroxyurea for the early management of chronic-phase- chronic myeloid leukemia: data from a real-world cohortSemantic proximity Read

Is there a best TKI for chronic phase CML?Semantic proximity Read

Safety and Efficacy of TKIs in Very Elderly Patients (≥75 Years) with Chronic Myeloid LeukemiaSemantic proximity Read

Optimizing second-line therapy for chronic myeloid leukemia.Semantic proximity Read

Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib – Final 6-year results from a Belgian registrySemantic proximity Read

Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib – final 6-year results from a Belgian registrySemantic proximity Read

Long-term outcome of Tyrosine Kinase Inhibitor treatment in children and adolescents with newly diagnosed chronic myeloid leukemia in chronic phase: A single-center experience in ChinaSemantic proximity Read

Evidence-Based Minireview: What is the optimal tyrosine kinase inhibitor for adults with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia?Semantic proximity Read

The impact of pretransplant use of tyrosine kinase inhibitors on allogeneic stem cell transplantation in patients with chronic myeloid leukemia - A single-institution retrospective studySemantic proximity Read